3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Venous Thrombosis
1
Upper Extremity Deep Vein Thrombosis
1
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Interventions
Cisplatin
32
Paclitaxel
29
Radiotherapy
21
Fluorouracil
20
Radiation
12
camrelizumab
11
Oxaliplatin
11
Docetaxel
11
Carboplatin
10
Capecitabine
9
Esophagectomy
8
Surgical Procedures, Operative
7
Radiotherapy, Intensity-Modulated
6
Leucovorin
6
Endoscopic Mucosal Resection
6
Drug Therapy
6
apatinib
5
Neoadjuvant Therapy
5
Chemoradiotherapy
5
nedaplatin
4
S 1 (combination)
4
Preoperative Exercise
4
Irinotecan
4
Endoscopy
4
Cetuximab
4
Albumin-Bound Paclitaxel
4
pembrolizumab
3
TP protocol
3
Radiotherapy, Adjuvant
3
Epirubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Esophageal Neoplasms
×
apixaban
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled